Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis - Blasi, Miriam; Eichhorn, Martin E.; Christopoulos, Petros; Winter, Hauke; Heußel, Claus Peter; Herth, Felix; El-Shafie, Rami; Kriegsmann, Katharina; Kriegsmann, Mark; Stenzinger, Albrecht; Bischoff, Helge; Thomas, Michael; et al. (BMC pulmonary medicine, 2022)
Gesehen am 18.08.2022